Cardialysis is a leading specialized Clinical Research Organization (CRO) with an exclusive focus on cardiology, providing a full range of clinical research and cardiovascular Core Laboratory services. Founded in 1983, Cardialysis is recognized for its opinion-leader expertise, strong academic network and in-depth cardiology expertise and in recent years has significantly expanded its operational activities. The world’s top medical device, biotechnology and pharmaceutical companies have been collaborating with Cardialysis in more than 350 clinical trials conducted up till now, contributing to improved cardiovascular therapies.
Structural heart Core Lab
The Cardialysis Structural Heart Core Lab provides the perfect partner in conducting TAVI/TAVR or prosthetic valve clinical trials. Over the past few years thousands of imaging data from patients enrolled in several registries and clinical trials have been successfully analyzed and adjudicated by the Cardialysis Core Lab. These data are used for both CE mark and FDA submissions.
Investigator initiated studies
The European Cardiovascular Research Institute (ECRI) provides a structure facilitating the design and conduct of clinical trials without the intention of making profit, yet according to ICH / GCP Guidelines and regulatory standards. This unique initiative between thought leaders in the field of cardiology and the expertise of Cardialysis .....
Cardialysis continues to expand its monitoring network within Europe. Our Clinical Research Associates have at least 5 years of experience, are well-trained, ensure activation of your sites, the highest quality review of data and effective interaction with study sites. With over 1600 sites monitored and more than 145,000 patients included, Cardialysis has established a strong cardiology track record.